Wegovy 0.25 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F94V9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,101
Award facts
- Contract value 100% obligated
- $11,100.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,100.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Wegovy (semaglutide) 0.25 mg/0.5 mL pens on December 9, 2025, with completion targeted for December 10, 2025. This non-set-aside delivery order will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the distributor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor serving military and veteran healthcare systems through the Defense Logistics Agency and its Medical Supply Chain. The company's extensive portfolio of federal contract awards demonstrates proven capability to deliver specialized pharmaceuticals across multiple therapeutic domains, from diabetes and neurological medications to pain management and antibiotics. This delivery order for Wegovy, a glucagon-like peptide-1 receptor agonist used in weight management and diabetes treatment, reflects the company's role in supplying prescription medications to support Defense Health Agency and other federal healthcare customers through competitively awarded contracts with firm fixed pricing structures.
Quick answers
Who was awarded contract SPE2DR26F94V9?
SPE2DR26F94V9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F94V9 worth?
The government has obligated $11,101 on SPE2DR26F94V9.
Is contract SPE2DR26F94V9 an order under another contract?
Yes. SPE2DR26F94V9 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F94V9 competed?
The extent of competition for SPE2DR26F94V9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award